☆ 4.7 Letter

Poly (ADP-ribose) polymerase (PARP) inhibitors for the treatment of advanced germline BRCA2 mutant prostate cancer

ANNALS OF ONCOLOGY (2013)

Get Full Text
Add to Collection

Journal

ANNALS OF ONCOLOGY
Volume 24, Issue 5, Pages 1416-1418

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/annonc/mdt074

Keywords

-

Categories

Oncology

Funding

  1. Cancer Research UK [14276, 13239, 16464] Funding Source: researchfish
  2. National Institute for Health Research [CL-2012-22-001, CL-2008-22-001] Funding Source: researchfish
  3. Cancer Research UK [13239] Funding Source: Medline
  4. Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline
  5. Department of Health [2197] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.